Connor, Clark & Lunn Investment Management (CC&L)’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $724K | Buy |
|
|||||
|
2024
Q2 | $151K | Sell |
|
|||||
|
2024
Q1 | $157K | Buy |
|
|||||
|
2023
Q4 | $125K | Buy |
|
|||||
|
2023
Q3 | $103K | Sell |
|
|||||
|
2023
Q2 | $193K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $231K | Sell |
|
|||||
|
2020
Q1 | $181K | Buy |
|
|||||
|
2019
Q4 | $445K | Buy |
|
|||||
|
2019
Q3 | $225K | Buy |
|
|||||
|
2019
Q2 | $241K | Buy |
|
|||||
|
2019
Q1 | $237K | Buy |
|
|||||
|
2018
Q4 | $183K | Buy |
|
|||||
|
2018
Q3 | $414K | Buy |
|
|||||
|
2018
Q2 | $523K | Buy |
|
|||||
|
2018
Q1 | $515K | Buy |
|
|||||
|
2017
Q4 | $329K | Buy |
|
|||||
|
2017
Q3 | $432K | Buy |
|
|||||
|
2017
Q2 | $271K | Buy |
|